Immune-related gene expression profiling and alectinib efficacy for patients with ALK-Rearranged non-small cell lung cancer: exploratory analysis of a prospective observational study.
Kurosaki T, Suzuki S, Watanabe Y, Kenmotsu H, Itoh S, Yamaguchi M, Shiono A, Suzuki T, Yokoyama T, Toi Y, Tanaka H, Oki M, Tsuda T, Ichihara E, Azuma K, Tanaka H, Arai R, Uchibori K, Miyauchi E, Katayama R, Hayashi H.
Kurosaki T, et al. Among authors: suzuki s.
Lung Cancer. 2026 Apr 19;216:109416. doi: 10.1016/j.lungcan.2026.109416. Online ahead of print.
Lung Cancer. 2026.
PMID: 42013562